Trade Roche Holding AG (Participation) - ROGz CFD
Add to favourite- Summary
- Historical Data
| Spread | 2.0 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.012132% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.01009% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | CHF | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Switzerland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 262.7 |
| Open | 266.1 |
| 1-Year Change | 6.48% |
| Day's Range | 263.4 - 266.6 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 16, 2025 | 262.7 | -2.7 | -1.02% | 265.4 | 267.7 | 262.7 |
| Jan 15, 2025 | 264.9 | 4.6 | 1.77% | 260.3 | 265.6 | 258.5 |
| Jan 14, 2025 | 263.6 | -2.6 | -0.98% | 266.2 | 268.2 | 262.6 |
| Jan 13, 2025 | 260.2 | -4.8 | -1.81% | 265.0 | 265.7 | 260.2 |
| Jan 10, 2025 | 264.8 | -3.7 | -1.38% | 268.5 | 270.9 | 264.7 |
| Jan 9, 2025 | 271.6 | 3.7 | 1.38% | 267.9 | 272.4 | 267.6 |
| Jan 8, 2025 | 264.8 | 0.5 | 0.19% | 264.3 | 268.1 | 263.6 |
| Jan 7, 2025 | 264.1 | 6.9 | 2.68% | 257.2 | 264.4 | 256.6 |
| Jan 6, 2025 | 252.5 | -4.3 | -1.67% | 256.8 | 257.3 | 252.5 |
| Jan 3, 2025 | 255.2 | -2.3 | -0.89% | 257.5 | 257.7 | 252.7 |
| Dec 30, 2024 | 252.3 | -0.3 | -0.12% | 252.6 | 255.1 | 252.2 |
| Dec 27, 2024 | 251.6 | 0.9 | 0.36% | 250.7 | 253.3 | 250.2 |
| Dec 23, 2024 | 250.0 | 2.0 | 0.81% | 248.0 | 251.0 | 243.3 |
| Dec 20, 2024 | 246.4 | 3.3 | 1.36% | 243.1 | 247.5 | 242.6 |
| Dec 19, 2024 | 245.4 | -5.4 | -2.15% | 250.8 | 251.0 | 245.0 |
| Dec 18, 2024 | 255.4 | -1.2 | -0.47% | 256.6 | 257.4 | 254.8 |
| Dec 17, 2024 | 254.8 | 6.0 | 2.41% | 248.8 | 257.7 | 248.8 |
| Dec 16, 2024 | 250.7 | 1.9 | 0.76% | 248.8 | 255.7 | 248.8 |
| Dec 13, 2024 | 252.5 | -1.4 | -0.55% | 253.9 | 254.3 | 251.7 |
| Dec 12, 2024 | 254.8 | 1.6 | 0.63% | 253.2 | 255.7 | 251.7 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Roche Company profile
About Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Roche Holding AG revenues increased 8% to SF62.8B. Net income decreased 3% to SF13.93B. Revenues reflect Diagnostics segment increase of 29% to SF17.76B, Chugai segment increase of 20% to SF4.51B, Rest of Europe segment increase of 16% to SF11.38B, Rest of Asia segment increase of 13% to SF9.75B, Germany segment increase of 29% to SF4.29B.
Equity composition
3 April 2001, 100 for 1 stock split.
| Industry: | Pharmaceuticals (NEC) |
Grenzacherstrasse 124
BASEL
BASEL-STADT 4058
CH
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com